Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12676
CALL
Accuray
ARAY
$33.2M
| $35.8K | ﹤0.01% |
18,100
+9,800
| +118% | +$18.5K |
|
12677
CALL
Great Southern Bancorp
GSBC
$889M
| $35.8K | ﹤0.01% |
600
+500
| +500% | +$30.4K |
|
12678
Mega Matrix
MPU
$14.3M
| $35.8K | ﹤0.01% |
25,755
-172,528
| -87% | -$264K |
|
12679
ARB IOT Group
ARBB
$7.93M
| $35.8K | ﹤0.01% |
4,855
+2,649
| +120% | +$18.6K |
|
|
MRC
12680
PUT
DELISTED
MRC Global
MRC
| $35.8K | ﹤0.01% |
2,800
-800
| -22% | -$10.5K |
|
12681
CALL
OmniAb
OABI
$491M
| $35.8K | ﹤0.01% |
10,100
+4,700
| +87% | +$18.6K |
|
|
DADA
12682
CALL
DELISTED
Dada Nexus
DADA
| $35.7K | ﹤0.01% |
29,500
-1,400
| -5% | -$2.24K |
|
12683
PUT
Red Robin
RRGB
$192M
| $35.7K | ﹤0.01% |
6,500
+3,100
| +91% | +$16.8K |
|
12684
PUT
Direxion Daily MSCI Emerging Markets Bear 3X ETF
EDZ
$18.6M
| $35.6K | ﹤0.01% |
390
-60
| -13% | -$4.84K |
|
12685
PUT
Sun Life Financial
SLF
$45.1B
| $35.6K | ﹤0.01% |
600
-70,600
| -99% | -$4.17M |
|
12686
CALL
Mercantile Bank Corp
MBWM
$1.06B
| $35.6K | ﹤0.01% |
800
-200
| -20% | -$9.29K |
|
12687
Alzamend Neuro
ALZN
$7.43M
| $35.5K | ﹤0.01% |
+3,404
| New | +$43.8K |
|
12688
PUT
Invesco Energy Exploration & Production ETF
PXE
$86.4M
| $35.5K | ﹤0.01% |
1,200
+500
| +71% | +$15.2K |
|
12689
PUT
Douglas Dynamics
PLOW
$976M
| $35.4K | ﹤0.01% |
1,500
-7,000
| -82% | -$177K |
|
|
MNTX
12690
CALL
DELISTED
Manitex International, Inc.
MNTX
| $35.4K | ﹤0.01% |
6,100
-12,500
| -67% | -$71.5K |
|
12691
CALL
Mitsubishi UFJ Financial
MUFG
$260B
| $35.2K | ﹤0.01% |
3,000
+400
| +15% | +$4.5K |
|
|
FOCL
12692
PUT
EDAP TMS S.A.
FOCL
$178M
| $35.1K | ﹤0.01% |
15,900
-3,000
| -16% | -$7.53K |
|
12693
PUT
Rockwell Medical
RMTI
$29.2M
| $35.1K | ﹤0.01% |
1,720
+1,030
| +149% | +$30K |
|
|
SONN
12694
DELISTED
Sonnet BioTherapeutics
SONN
| $35.1K | ﹤0.01% |
+24,013
| New | +$83.8K |
|
|
12695
PUT
OmniAb
OABI
$491M
| $35K | ﹤0.01% |
9,900
-13,200
| -57% | -$52.2K |
|
12696
PUT
Crane NXT
CXT
$2.97B
| $34.9K | ﹤0.01% |
600
-3,100
| -84% | -$178K |
|
12697
PUT
Tradr 2X Long Innovation ETF
TARK
$16.3M
| $34.9K | ﹤0.01% |
800
-1,200
| -60% | -$48.6K |
|
12698
CALL
Adecoagro
AGRO
$1.29B
| $34.9K | ﹤0.01% |
3,700
-8,900
| -71% | -$97.1K |
|
12699
CALL
VanEck Social Sentiment ETF
BUZZ
$103M
| $34.8K | ﹤0.01% |
1,400
-6,900
| -83% | -$165K |
|
|
BKYI
12700
BIO-key International
BKYI
$3.46M
| $34.8K | ﹤0.01% |
+2,033
| New | +$19.8K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.